Per Christer Sjöberg

DakoCytomation is a company highly specialized in systems solutions for diagnostic and research use. Since its beginning in 1966, it has a tradition of being a company where human and caring aspects matter, both within the company and towards its business partners. It is the leading provider of pharmDx™ cancer diagnostic tests.

Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark.

DermaGen AB develops drugs and medical devices. It focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. The company was founded on February 2, 2004 and is headquartered in Solna, Sweden.

Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden.

QuickCool AB engages in the development, production, and sales of medical equipment. It develops a cooling system for the brain and the body that goes in through the nasal cavity in order to maintain safe body temperature of patients with high grade fever, head trauma, and heart diseases as well as those in the intensive care. The company was founded by Lennart Sjölund, Tadeusz Wojciech Wieloch, Anders Lunderquist, Fredrik Boris-Möller, and Mats Allers in 2003 and is headquartered in Lund, Sweden.

Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.

Perstorp AB manufactures and supplies specialty chemicals. The company was founded in 1881 and is headquartered in Perstorp, Sweden.